Francisco Martinez‐Sandoval

1.3k total citations
15 papers, 800 citations indexed

About

Francisco Martinez‐Sandoval is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Hepatology. According to data from OpenAlex, Francisco Martinez‐Sandoval has authored 15 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 6 papers in Infectious Diseases and 5 papers in Hepatology. Recurrent topics in Francisco Martinez‐Sandoval's work include Travel-related health issues (11 papers), Viral gastroenteritis research and epidemiology (5 papers) and Hepatitis Viruses Studies and Epidemiology (4 papers). Francisco Martinez‐Sandoval is often cited by papers focused on Travel-related health issues (11 papers), Viral gastroenteritis research and epidemiology (5 papers) and Hepatitis Viruses Studies and Epidemiology (4 papers). Francisco Martinez‐Sandoval collaborates with scholars based in Mexico, United States and Jamaica. Francisco Martinez‐Sandoval's co-authors include Herbert L. DuPont, Charles D. Ericsson, Margaret W. DuPont, John J. Mathewson, Javier A. Adachi, Pablo C. Okhuysen, Zhi‐Dong Jiang, Zhi‐Dong Jiang, F.J. de la Cabada and D. Ashley and has published in prestigious journals such as Annals of Internal Medicine, Gastroenterology and Clinical Infectious Diseases.

In The Last Decade

Francisco Martinez‐Sandoval

15 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francisco Martinez‐Sandoval Mexico 13 468 339 288 143 103 15 800
Margaret W. DuPont United States 13 598 1.3× 369 1.1× 354 1.2× 129 0.9× 129 1.3× 17 880
Zhi‐Dong Jiang United States 17 316 0.7× 341 1.0× 197 0.7× 203 1.4× 117 1.1× 22 931
Charles D. Ericsson United States 9 235 0.5× 190 0.6× 153 0.5× 89 0.6× 58 0.6× 10 399
John W. Sanders United States 11 368 0.8× 296 0.9× 116 0.4× 32 0.2× 53 0.5× 13 664
Thomas Haustein Switzerland 10 114 0.2× 280 0.8× 27 0.1× 33 0.2× 17 0.2× 16 680
Bich-Tram Huynh France 16 296 0.6× 52 0.2× 27 0.1× 84 0.6× 27 0.3× 38 721
I Kabir Bangladesh 19 52 0.1× 358 1.1× 22 0.1× 347 2.4× 153 1.5× 39 907
Mohammad Juffrie Indonesia 17 526 1.1× 458 1.4× 12 0.0× 9 0.1× 151 1.5× 81 1.2k
Decy Subekti Indonesia 16 206 0.4× 305 0.9× 50 0.2× 140 1.0× 76 0.7× 27 666
H. Mittermayer Austria 17 61 0.1× 324 1.0× 20 0.1× 88 0.6× 56 0.5× 46 843

Countries citing papers authored by Francisco Martinez‐Sandoval

Since Specialization
Citations

This map shows the geographic impact of Francisco Martinez‐Sandoval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco Martinez‐Sandoval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco Martinez‐Sandoval more than expected).

Fields of papers citing papers by Francisco Martinez‐Sandoval

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francisco Martinez‐Sandoval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco Martinez‐Sandoval. The network helps show where Francisco Martinez‐Sandoval may publish in the future.

Co-authorship network of co-authors of Francisco Martinez‐Sandoval

This figure shows the co-authorship network connecting the top 25 collaborators of Francisco Martinez‐Sandoval. A scholar is included among the top collaborators of Francisco Martinez‐Sandoval based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francisco Martinez‐Sandoval. Francisco Martinez‐Sandoval is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Martinez‐Sandoval, Francisco, Charles D. Ericsson, Zhi‐Dong Jiang, et al.. (2010). Prevention of Travelers' Diarrhea With Rifaximin in US Travelers to Mexico. Journal of Travel Medicine. 17(2). 111–117. 29 indexed citations
2.
3.
Martinez‐Sandoval, Francisco, et al.. (2009). [Multivariate model to predict Streptococcus pyogenes tonsillitis].. PubMed. 46(4). 383–90. 2 indexed citations
4.
Nair, Parvathy, Mohamed A. Jamal, Herbert L. DuPont, et al.. (2008). Epidemiology of Cryptosporidiosis in North American Travelers to Mexico. American Journal of Tropical Medicine and Hygiene. 79(2). 210–214. 20 indexed citations
5.
Grimes, Kevin A., Mohamed A. Jamal, Herbert L. DuPont, et al.. (2008). PCR-Based Assay Using Occult Blood Detection Cards for Detection of Diarrheagenic Escherichia coli in Specimens from U.S. Travelers to Mexico with Acute Diarrhea. Journal of Clinical Microbiology. 46(7). 2227–2230. 21 indexed citations
6.
Torres-Bugarı́n, Olivia, et al.. (2007). Anabolic androgenic steroids induce micronuclei in buccal mucosa cells of bodybuilders. British Journal of Sports Medicine. 41(9). 592–596. 34 indexed citations
7.
DuPont, Herbert L., Charles D. Ericsson, F.J. de la Cabada, et al.. (2006). Prevention of Travelersʼ Diarrhea with Rifaximin – A Phase 3 Randomized Double-Blind Placebo-Controlled Trial in U.S. Students in Mexico. The American Journal of Gastroenterology. 101. S197–S198. 4 indexed citations
8.
DuPont, Herbert L., Zhi‐Dong Jiang, Pablo C. Okhuysen, et al.. (2005). Antibacterial Chemoprophylaxis in the Prevention of Traveler's Diarrhea: Evaluation of Poorly Absorbed Oral Rifaximin. Clinical Infectious Diseases. 41(Supplement_8). S571–S576. 17 indexed citations
9.
DuPont, Herbert L., Zhi‐Dong Jiang, Pablo C. Okhuysen, et al.. (2005). A Randomized, Double-Blind, Placebo-Controlled Trial of Rifaximin To Prevent Travelers' Diarrhea. Annals of Internal Medicine. 142(10). 805–812. 161 indexed citations
10.
Adachi, Javier A., C. D. Ericsson, Margaret W. DuPont, et al.. (2003). Azithromycin Found to Be Comparable to Levofloxacin for the Treatment of US Travelers with Acute Diarrhea Acquired in Mexico. Clinical Infectious Diseases. 37(9). 1165–1171. 78 indexed citations
11.
DuPont, Herbert L., John J. Mathewson, D. Ashley, et al.. (2002). A double blind, randomized, placebo-controlled study of SP-303 (Provir) in the symptomatic treatment of acute diarrhea among travelers to Jamaica and Mexico. The American Journal of Gastroenterology. 97(10). 2585–2588. 44 indexed citations
12.
Adachi, Javier A., Zhi‐Dong Jiang, John J. Mathewson, et al.. (2001). EnteroaggregativeEscherichia colias a Major Etiologic Agent in Traveler's Diarrhea in 3 Regions of the World. Clinical Infectious Diseases. 32(12). 1706–1709. 154 indexed citations
13.
DuPont, Herbert L., Zhi‐Dong Jiang, Charles D. Ericsson, et al.. (2001). Rifaximin versus Ciprofloxacin for the Treatment of Traveler's Diarrhea: A Randomized, Double‐Blind Clinical Trial. Clinical Infectious Diseases. 33(11). 1807–1815. 138 indexed citations
14.
Okhuysen, Pablo C., et al.. (1995). Zaldaride Maleate (a New Calmodulin Antagonist) Versus Loperamide in the Treatment of Traveler's Diarrhea: Randomized, Placebo-Controlled Trial. Clinical Infectious Diseases. 21(2). 341–344. 25 indexed citations
15.
DuPont, Herbert L., et al.. (1993). Zaldaride maleate, an intestinal calmodulin inhibitor, in the therapy of travelers' diarrhea. Gastroenterology. 104(3). 709–715. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret W. DuPont Breakdown of academic impact, for papers by Zhi‐Dong Jiang Breakdown of academic impact, for papers by Charles D. Ericsson Breakdown of academic impact, for papers by John W. Sanders Breakdown of academic impact, for papers by Thomas Haustein Breakdown of academic impact, for papers by Bich-Tram Huynh Breakdown of academic impact, for papers by I Kabir Breakdown of academic impact, for papers by Mohammad Juffrie Breakdown of academic impact, for papers by Decy Subekti Breakdown of academic impact, for papers by H. Mittermayer
Rankless by CCL
2026